Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

liposomal doxorubicin hydrochloride

(LY-poh-SOH-mul DOK-soh-ROO-bih-sin HY-droh-KLOR-ide)
A form of the anticancer drug doxorubicin that is contained inside very tiny, fat-like particles and is used alone or with other drugs to treat certain types of ovarian cancer, AIDS-related Kaposi sarcoma, and multiple myeloma. Liposomal doxorubicin hydrochloride may have fewer side effects and work better than other forms of doxorubicin hydrochloride. It is also being studied in the treatment of other types of cancer. Liposomal doxorubicin hydrochloride is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Doxil and doxorubicin hydrochloride liposome.
More Information
Search NCI's Dictionary of Cancer Terms